Skip to content
Home » privateequity

privateequity

Founder Exits After the April 2026 Tax Changes

    For business owners, the tax implications of selling a company changed in April 2026, and planning transactions has changed with this. Business Asset Disposal Relief, which had already risen once, increased again to 18% from 6 April 2026.

    Mid-Market Activity Has Turned Since February

      European leveraged loan issuance reached €22.7bn in Q1 2026, the weakest first quarter since 2023, and direct lending volume fell 33% year on year. The headline data describes a slowing market. The conversations we have had this month with advisers and lenders describe a different one.

      Private Equity Is Rolling Up European Fertility

        Fertility has become one of the clearest examples of consolidation in European healthcare. Demand is rising structurally, the market remains fragmented across independent and small clinic groups, and private equity has moved in to scale.

        Private Equity’s Exit Problem Is a Middle Market Problem

          Private equity had a better year for exits in 2025, but the recovery was uneven. Allianz Research put global sponsor exit value at around $905bn for the year, yet roughly three quarters of that came from a small number of very large deals.

          Reverse Takeovers, the Pros and Cons for European Companies

            A reverse takeover lets a private company gain a public listing by combining with a company that is already listed, rather than through an IPO. We recently advised on a transaction of this type involving a Swedish listed company on the Nordic Growth Market, due to be announced in the coming weeks.

            The Silver Tsunami Has Concentrated in Industrial Services

              The “Silver Tsunami” trend has become a key theme in the UK private equity space. Two separate UK industrial services businesses crossed our desk this month with the same profile: founder owners nearing retirement with no family successor, turnover in the £15m to £30m range, and a willingness to step back over three to four years rather than exit the business entirely on completion.

              European Pharmacy Is Going Omnichannel

                Europe’s online pharmacy platforms have spent the last decade building something valuable – large, loyal digital customer bases across multiple markets and channels. The question now is how that value is best realised, and increasingly the answer is in combination.

                Growth Companies Continue to Choose Private Equity

                  Europe’s IPO reform agenda has been in motion for more than two years and despite listing requirements being relaxed, growth companies across all sectors continue to choose private capital over raising capital from the public markets.